Pulse Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€46.17M +26.9% N/A -€31.20M +10.0% N/A
    €0.00 -100.0% -€36.37M -28.4% N/A -€28.36M -29.4% N/A
    €603.08K -50.6% -€50.79M -6.7% -8,421.9% -40 pp -€40.16M -13.1% -6,658.9% -29 pp
    €1.22M +∞% -€54.42M +27.0% -4,454.2% -45 pp -€46.23M +53.6% -3,784.2% -38 pp
    €0.00 +NaN% -€42.85M +8.2% N/A -€30.09M +4.0% N/A
    €0.00 +NaN% -€39.62M +22.5% N/A -€28.93M +42.2% N/A
    €0.00 +NaN% -€32.35M +46.8% N/A -€20.35M +176.7% N/A
    €0.00 +NaN% -€22.03M +168.6% N/A -€7.35M +6.9% N/A
    €0.00 +NaN% -€8.20M +238.6% N/A -€6.88M +147.2% N/A
    €0.00 +NaN% -€2.42M +492.0% N/A -€2.78M +3,326.5% N/A
    €0.00 -€409.11K N/A -€81.23K N/A

    Notifications